Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study.
KDOQI practice guidelines recommend predialysis blood pressure <140/90 mm Hg; however, most prior studies had found elevated mortality with low, not high, systolic blood pressure. This is possibly due to unmeasured confounders affecting systolic blood pressure and mortality. To lessen this bias, we analyzed 24,525 patients by Cox regression models adjusted for patient and facility characteristics. Compared with predialysis systolic blood pressure of 130-159 mm Hg, mortality was 13% higher in facilities with 20% more patients at systolic blood pressure of 110-129 mm Hg and 16% higher in facilities with 20% more patients at systolic blood pressure of ≥160 mm Hg. For patient-level systolic blood pressure, mortality was elevated at low (<130 mm Hg), not high (≥180 mm Hg), systolic blood pressure. For predialysis diastolic blood pressure, mortality was lowest at 60-99 mm Hg, a wide range implying less chance to improve outcomes. Higher mortality at systolic blood pressure of <130 mm Hg is consistent with prior studies and may be due to excessive blood pressure lowering during dialysis. The lowest risk facility systolic blood pressure of 130-159 mm Hg indicates this range may be optimal, but may have been influenced by unmeasured facility practices. While additional study is needed, our findings contrast with KDOQI blood pressure targets, and provide guidance on optimal blood pressure range in the absence of definitive clinical trial data.
Arbor Research Collaborative for Health, Ann Arbor, MI, USA. bruce.robinson@arborresearch.org
Bruce M
BM
Robinson
Lin
L
Tong
Jinyao
J
Zhang
Robert A
RA
Wolfe
David A
DA
Goodkin
Roger N
RN
Greenwood
Peter G
PG
Kerr
Hal
H
Morgenstern
Yun
Y
Li
Ronald L
RL
Pisoni
Rajiv
R
Saran
Francesca
F
Tentori
Tadao
T
Akizawa
Shunichi
S
Fukuhara
Friedrich K
FK
Port
D001315:Australia; D001794:Blood Pressure; D015897:Comorbidity; D003430:Cross-Sectional Studies; D005060:Europe; D005260:Female; D006801:Humans; D006973:Hypertension / Q000401:mortality* / Q000503:physiopathology; D007564:Japan; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000628:therapy*; D016014:Linear Models; D008297:Male; D008875:Middle Aged; D009520:New Zealand; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000592:standards / Q000706:statistics & numerical data*; D016016:Proportional Hazards Models; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects / Q000401:mortality* / Q000592:standards; D018570:Risk Assessment; D012307:Risk Factors; D016896:Treatment Outcome; D014481:United States